Expression and clinical significance of CD44 and Ezrin in the process of metastasis in human primary sporadic colorectal carcinoma

颜歌,杜祥,周晓燕,陆洪芬
DOI: https://doi.org/10.3760/j.issn:0254-1432.2007.08.002
2007-01-01
Abstract:Objective To study the expression,relationship and the clinical significance of CD44 and Ezrin in metastatic human sporadic colorectal carcinoma(SCRC)and non-metastatic colorectal carci- noma.Methods Immunohistological EnVision staining was used to detect the expressions of CD44 and Ezrin in 132 cases of SCRC,including 74 metastatic cases and 58 non-metastatic cases.Statistic analysis was done by SPSS 12.0 software package to study the correlation and their clinical prognostic value. Results The expression of CD44 was significantly higher in metastatic group(71.6%)than that in non- metastatic group(53.4%,P=0.031),and the expression of Ezrin in metastatic group(86.5%)was significantly different from that in non-metastatic group(70.7%,P=0.026),the rate of CD44 and Ezrin coexpression was significantly higher in metastatic group(63.5%)than that in non-metastatic group(43.1%,P=0.019).The expression of CD44 was positively correlated with Ezrin in colorectal carcinoma(P=0.020,r=0.202).There was no relationship between the expression of CD44 and Ezrin with age,sex,tumor size,location,differentiation of malignance or invasive depth(P>0.05).In the followed-up patients,univariant analysis demonstrated that the expressions of CD44 and Ezrin and their coexpression were correlated with disease free survival(DFS)rate(P<0.05);multivariate ana-lysis in- dicated that CD44 and Ezrin coexpression was an independent prognostic factor of colorectal carcinoma(P<0.05).Conclusions The increase of CD44 and Ezrin expressions are closely correlated with metasta- sis of SCRC.It might be correlated between CD44 and Ezrin expression,and their coexpression might be used as a prognostic factor of SCRC.
What problem does this paper attempt to address?